Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice

Ophthalmology. 2011 Jul;118(7):1227-8. doi: 10.1016/j.ophtha.2011.04.028.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Clinical Trials, Phase II as Topic
  • Diffusion of Innovation*
  • Humans
  • Infant, Newborn
  • Multicenter Studies as Topic
  • Neovascularization, Pathologic / etiology*
  • Neovascularization, Pathologic / prevention & control*
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Retinopathy of Prematurity / complications*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab